213 related articles for article (PubMed ID: 19606426)
21. Influence of the papiliocin peptide derived from Papilio xuthus on the perturbation of fungal cell membranes.
Lee J; Hwang JS; Hwang B; Kim JK; Kim SR; Kim Y; Lee DG
FEMS Microbiol Lett; 2010 Oct; 311(1):70-5. PubMed ID: 20707816
[TBL] [Abstract][Full Text] [Related]
22. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
Papo N; Shai Y
Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621
[TBL] [Abstract][Full Text] [Related]
23. Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides.
Chen Y; Vasil AI; Rehaume L; Mant CT; Burns JL; Vasil ML; Hancock RE; Hodges RS
Chem Biol Drug Des; 2006 Feb; 67(2):162-73. PubMed ID: 16492164
[TBL] [Abstract][Full Text] [Related]
24. Effect of Leucine and Lysine substitution on the antimicrobial activity and evaluation of the mechanism of the HPA3NT3 analog peptide.
Gopal R; Park SC; Ha KJ; Cho SJ; Kim SW; Song PI; Nah JW; Park Y; Hahm KS
J Pept Sci; 2009 Sep; 15(9):589-94. PubMed ID: 19642077
[TBL] [Abstract][Full Text] [Related]
25. Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides.
Epand RF; Mowery BP; Lee SE; Stahl SS; Lehrer RI; Gellman SH; Epand RM
J Mol Biol; 2008 May; 379(1):38-50. PubMed ID: 18440552
[TBL] [Abstract][Full Text] [Related]
26. Antifungal mechanism of an antimicrobial peptide, HP (2--20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans.
Lee DG; Park Y; Kim HN; Kim HK; Kim PI; Choi BH; Hahm KS
Biochem Biophys Res Commun; 2002 Mar; 291(4):1006-13. PubMed ID: 11866466
[TBL] [Abstract][Full Text] [Related]
27. Properties and structure-activity studies of cyclic beta-hairpin peptidomimetics based on the cationic antimicrobial peptide protegrin I.
Robinson JA; Shankaramma SC; Jetter P; Kienzl U; Schwendener RA; Vrijbloed JW; Obrecht D
Bioorg Med Chem; 2005 Mar; 13(6):2055-64. PubMed ID: 15727859
[TBL] [Abstract][Full Text] [Related]
28. Parallel and antiparallel dimers of magainin 2: their interaction with phospholipid membrane and antibacterial activity.
Mukai Y; Matsushita Y; Niidome T; Hatekeyama T; Aoyag H
J Pept Sci; 2002 Oct; 8(10):570-7. PubMed ID: 12450326
[TBL] [Abstract][Full Text] [Related]
29. Influence of the N- and C-terminal regions of antimicrobial peptide pleurocidin on antibacterial activity.
Cho J; Choi H; Lee DG
J Microbiol Biotechnol; 2012 Oct; 22(10):1367-74. PubMed ID: 23075787
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial peptides derived from growth factors.
Malmsten M; Davoudi M; Walse B; Rydengård V; Pasupuleti M; Mörgelin M; Schmidtchen A
Growth Factors; 2007 Feb; 25(1):60-70. PubMed ID: 17454151
[TBL] [Abstract][Full Text] [Related]
31. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides.
Rosenfeld Y; Sahl HG; Shai Y
Biochemistry; 2008 Jun; 47(24):6468-78. PubMed ID: 18498177
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli.
van der Kraan MI; van Marle J; Nazmi K; Groenink J; van 't Hof W; Veerman EC; Bolscher JG; Nieuw Amerongen AV
Peptides; 2005 Sep; 26(9):1537-42. PubMed ID: 16112390
[TBL] [Abstract][Full Text] [Related]
33. De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.
Kang SJ; Won HS; Choi WS; Lee BJ
J Pept Sci; 2009 Sep; 15(9):583-8. PubMed ID: 19544481
[TBL] [Abstract][Full Text] [Related]
34. Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action.
Yang ST; Lee JY; Kim HJ; Eu YJ; Shin SY; Hahm KS; Kim JI
FEBS J; 2006 Sep; 273(17):4040-54. PubMed ID: 16889633
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the antimicrobial peptide melimine with bacterial membranes.
Rasul R; Cole N; Balasubramanian D; Chen R; Kumar N; Willcox MD
Int J Antimicrob Agents; 2010 Jun; 35(6):566-72. PubMed ID: 20227248
[TBL] [Abstract][Full Text] [Related]
36. Stable expression of bioactive recombinant pleurocidin in a fish cell line.
Brocal I; Falco A; Mas V; Rocha A; Perez L; Coll JM; Estepa A
Appl Microbiol Biotechnol; 2006 Oct; 72(6):1217-28. PubMed ID: 16636829
[TBL] [Abstract][Full Text] [Related]
37. Cell specificity, anti-inflammatory activity, and plausible bactericidal mechanism of designed Trp-rich model antimicrobial peptides.
Park KH; Nan YH; Park Y; Kim JI; Park IS; Hahm KS; Shin SY
Biochim Biophys Acta; 2009 May; 1788(5):1193-203. PubMed ID: 19285481
[TBL] [Abstract][Full Text] [Related]
38. Rationally designed antimicrobial peptides: Insight into the mechanism of eleven residue peptides against microbial infections.
Pandit G; Biswas K; Ghosh S; Debnath S; Bidkar AP; Satpati P; Bhunia A; Chatterjee S
Biochim Biophys Acta Biomembr; 2020 Apr; 1862(4):183177. PubMed ID: 31954105
[TBL] [Abstract][Full Text] [Related]
39. Membrane selectivity by W-tagging of antimicrobial peptides.
Schmidtchen A; Ringstad L; Kasetty G; Mizuno H; Rutland MW; Malmsten M
Biochim Biophys Acta; 2011 Apr; 1808(4):1081-91. PubMed ID: 21192916
[TBL] [Abstract][Full Text] [Related]
40. D-form KLKLLLLLKLK-NH
Manabe T; Kawasaki K
Sci Rep; 2017 Mar; 7():43384. PubMed ID: 28262682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
